Clinical application of phospholipid liposomes containing macrophage activators for therapy of cancer metastasis

This publication has 25 references indexed in Scilit:

• Modulation of Monocyte Functions by Muramyl Triptide Phosphatidylethanolamine in a Phase II Study in Patients With Metastatic Melanoma
  JNCI Journal of the National Cancer Institute, 1992
• Therapy for Osteosarcoma in Dogs With Intravenous Injection of Liposome-Encapsulated Muramyl Tripeptide
  JNCI Journal of the National Cancer Institute, 1989
• Targeting of immunomodulators to mononuclear phagocytes for therapy of cancer
  Advanced Drug Delivery Reviews, 1988
• The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the Extremity
  New England Journal of Medicine, 1986
• Delivery of liposome-encapsulated drugs to macrophages
  Pharmacology & Therapeutics, 1983
• Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines.
  Journal of Clinical Investigation, 1983
• Prostaglandin E2 modulation of human monocyte antibody-dependent cell-mediated cytotoxicity against human red blood cells
  Cellular Immunology, 1982
• Synthetic immunostimulants derived from the bacterial cell wall
  Journal of Medicinal Chemistry, 1980
• Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse
  International Journal of Immunopharmacology, 1979
• A computer program for comparing K samples with right-censored data
  Computer Programs in Biomedicine, 1972